Clinical trial
A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in…
NCT00260988 · Ottawa Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00260988 |
|---|---|
| Title | A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery |
| Official title | Tinzaparin Versus Dalteparin for Perioperative Thromboembolic Prophylaxis in Patients With Dialysis Dependent Renal Disease- A Canadian Multicentre Trial |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Collaborators | LEO Pharma Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Thromboembolism, Hemodialysis |
| Intervention type | Drug |
| Interventions | Fragmin (dalteparin), Innohep (tinzaparin) |
| Enrollment | 29 |
| Start date | Oct 1, 2003 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Dec 2, 2005 |
| Last update posted | Sep 10, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: